Failure to Complete Required AIMS Test for Resident on Antipsychotic Medication
Penalty
Summary
The facility failed to complete an Abnormal Involuntary Movement Scale (AIMS) test for a resident who was prescribed an antipsychotic medication, Olanzapine, upon admission. According to the facility's policy, an AIMS test should be performed when a resident is admitted on antipsychotic medications, every six months, and as needed. Record review showed that the resident, who had diagnoses including dementia with agitation and delirium and was severely cognitively impaired, was receiving Olanzapine as ordered by the physician. However, there was no documentation of an AIMS test being completed for this resident. Interviews with facility staff, including the Resident Care Manager/RN and the Director of Nursing/RN, confirmed that an AIMS test should have been completed upon admission and when the antipsychotic medication was started. Both staff members acknowledged that the AIMS test was missed for this resident, and it was not found in the resident's electronic health record. This omission was identified during the review of records and staff interviews.